Yuhan Corporation - Product Pipeline Review - 2015

  • ID: 3440644
  • Company Profile
  • 49 pages
  • Global Markets Direct
1 of 4
Yuhan Corporation - Product Pipeline Review - 2015

Summary

The report ‘Yuhan Corporation - Product Pipeline Review - 2015’, provides an overview of the Yuhan Corporation’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Yuhan Corporation’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updates following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Yuhan Corporation including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Yuhan Corporation’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Yuhan Corporation’s pipeline products

Reasons to buy

- Evaluate Yuhan Corporation’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Yuhan Corporation in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Yuhan Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Yuhan Corporation and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Yuhan Corporation
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Yuhan Corporation and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Yuhan Corporation Snapshot

Yuhan Corporation Overview

Key Information

Key Facts

Yuhan Corporation - Research and Development Overview

Key Therapeutic Areas

Yuhan Corporation - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Yuhan Corporation - Pipeline Products Glance

Yuhan Corporation - Late Stage Pipeline Products

Phase III Products/Combination Treatment Modalities

Yuhan Corporation - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Yuhan Corporation - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Yuhan Corporation - Drug Profiles

(rosuvastatin calcium + metformin SR)

Product Description

Mechanism of Action

R&D Progress

bilastine

Product Description

Mechanism of Action

R&D Progress

YH-4808

Product Description

Mechanism of Action

R&D Progress

YH-14618

Product Description

Mechanism of Action

R&D Progress

YH-12852

Product Description

Mechanism of Action

R&D Progress

YH-22162

Product Description

Mechanism of Action

R&D Progress

YH-22189

Product Description

Mechanism of Action

R&D Progress

YHB-14112

Product Description

Mechanism of Action

R&D Progress

YH-1177

Product Description

Mechanism of Action

R&D Progress

YH-14619

Product Description

Mechanism of Action

R&D Progress

YH-14810

Product Description

Mechanism of Action

R&D Progress

YH-18420

Product Description

Mechanism of Action

R&D Progress

YH-GKA

Product Description

Mechanism of Action

R&D Progress

YH-22241

Product Description

Mechanism of Action

R&D Progress

YH-BIO

Product Description

Mechanism of Action

R&D Progress

YH-NCE

Product Description

Mechanism of Action

R&D Progress

YH-NCE2

Product Description

Mechanism of Action

R&D Progress

YH-NCE3

Product Description

Mechanism of Action

R&D Progress

Yuhan Corporation - Pipeline Analysis

Yuhan Corporation - Pipeline Products by Target

Yuhan Corporation - Pipeline Products by Route of Administration

Yuhan Corporation - Pipeline Products by Molecule Type

Yuhan Corporation - Pipeline Products by Mechanism of Action

Yuhan Corporation - Recent Pipeline Updates

Yuhan Corporation - Dormant Projects

Yuhan Corporation - Company Statement

Yuhan Corporation - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Yuhan Corporation - Key Manufacturing Facilities

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Yuhan Corporation, Key Information

Yuhan Corporation, Key Facts

Yuhan Corporation - Pipeline by Indication, 2015

Yuhan Corporation - Pipeline by Stage of Development, 2015

Yuhan Corporation - Monotherapy Products in Pipeline, 2015

Yuhan Corporation - Combination Treatment Modalities in Pipeline, 2015

Yuhan Corporation - Partnered Products in Pipeline, 2015

Yuhan Corporation - Partnered Products/ Combination Treatment Modalities, 2015

Yuhan Corporation - Phase III, 2015

Yuhan Corporation - Phase II, 2015

Yuhan Corporation - Phase I, 2015

Yuhan Corporation - Preclinical, 2015

Yuhan Corporation - Discovery, 2015

Yuhan Corporation - Pipeline by Target, 2015

Yuhan Corporation - Pipeline by Route of Administration, 2015

Yuhan Corporation - Pipeline by Molecule Type, 2015

Yuhan Corporation - Pipeline Products by Mechanism of Action, 2015

Yuhan Corporation - Recent Pipeline Updates, 2015

Yuhan Corporation - Dormant Developmental Projects,2015

Yuhan Corporation, Other Locations

Yuhan Corporation, Subsidiaries

Yuhan Corporation, Key Manufacturing Facilities

List of Figures

Yuhan Corporation - Pipeline by Top 10 Indication, 2015

Yuhan Corporation - Pipeline by Stage of Development, 2015

Yuhan Corporation - Monotherapy Products in Pipeline, 2015

Yuhan Corporation - Partnered Products in Pipeline, 2015

Yuhan Corporation - Pipeline by Top 10 Target, 2015

Yuhan Corporation - Pipeline by Top 10 Route of Administration, 2015

Yuhan Corporation - Pipeline by Top 10 Molecule Type, 2015

Yuhan Corporation - Pipeline Products by Top 10 Mechanism of Action, 2015
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll